12 | Peptides (Polypeptides)IBA
01/2024
-
04/2010 |
9 | Radioisotopes (Radionuclides)IBA
11/2023
-
12/2014 |
6 | CopperIBA
09/2023
-
12/2011 |
5 | RadiopharmaceuticalsIBA
01/2023
-
01/2019 |
4 | BombesinIBA
01/2019
-
04/2010 |
3 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2024
-
01/2019 |
3 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2024
-
11/2022 |
3 | Biomarkers (Surrogate Marker)IBA
01/2024
-
01/2018 |
3 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022
-
03/2016 |
3 | Glucose (Dextrose)FDA LinkGeneric
01/2022
-
01/2013 |
3 | SurvivinIBA
01/2019
-
01/2017 |
3 | sodium-iodide symporter (sodium iodide symporter)IBA
01/2019
-
01/2017 |
2 | PorphyrinsIBA
05/2024
-
01/2021 |
2 | PolymersIBA
11/2023
-
01/2023 |
2 | Phosphotransferases (Kinase)IBA
01/2022
-
01/2016 |
2 | Zirconium-89IBA
01/2022
-
01/2019 |
2 | Amino AcidsFDA Link
01/2022
-
09/2021 |
2 | IodineIBA
11/2021
-
01/2020 |
2 | Proteins (Proteins, Gene)FDA Link
11/2021
-
12/2014 |
2 | Technetium Tc 99m MedronateIBA
01/2021
-
10/2020 |
2 | Therapeutic UsesIBA
01/2021
-
10/2020 |
2 | Bombesin Receptors (Bombesin Receptor)IBA
01/2020
-
01/2013 |
2 | Copper Transporter 1IBA
01/2018
-
04/2014 |
2 | Iodine-131IBA
01/2018
-
01/2018 |
2 | Cisplatin (Platino)FDA LinkGeneric
01/2018
-
01/2018 |
2 | Antineoplastic Agents (Antineoplastics)IBA
01/2018
-
12/2010 |
2 | AntibodiesIBA
01/2014
-
02/2009 |
2 | 6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
02/2011
-
08/2010 |
1 | tetra-4-amidinophenoxypropane (TAPP)IBA
05/2024 |
1 | UCON 50-HB-5100 (F127)IBA
05/2024 |
1 | tetracarboxyphenylporphineIBA
05/2024 |
1 | Carbon Tetrachloride (Tetrachloromethane)IBA
01/2024 |
1 | Radioactive TracersIBA
01/2024 |
1 | Gallium-68IBA
01/2024 |
1 | Transferrin Receptors (Transferrin Receptor)IBA
01/2024 |
1 | AlloysIBA
11/2023 |
1 | Amyloid (Amyloid Fibrils)IBA
10/2023 |
1 | tetrathiomolybdate (ammonium tetrathiomolybdate)IBA
09/2023 |
1 | Mechanistic Target of Rapamycin Complex 1IBA
09/2023 |
1 | Sirolimus (Rapamycin)FDA Link
09/2023 |
1 | LigandsIBA
01/2023 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2023 |
1 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022 |
1 | IntegrinsIBA
01/2022 |
1 | Tyrosine (L-Tyrosine)FDA Link
01/2022 |
1 | AstatineIBA
11/2021 |
1 | Angiopep-2IBA
01/2021 |
1 | Melanins (Melanin)IBA
10/2020 |
1 | Natriuretic PeptidesIBA
01/2020 |
1 | Testosterone PropionateFDA Link
01/2020 |
1 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020 |
1 | Interleukin-10 (Interleukin 10)IBA
01/2020 |
1 | Biocompatible Materials (Biomaterials)IBA
01/2020 |
1 | AntigensIBA
01/2019 |
1 | phosphorylethanolamine (phosphoethanolamine)IBA
01/2019 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2019 |
1 | ferric oxide (iron oxide)IBA
01/2019 |
1 | Coloring Agents (Dyes)IBA
01/2019 |
1 | MicellesIBA
01/2019 |
1 | Contrast MediaIBA
01/2019 |
1 | Sulfides (Thioethers)IBA
07/2018 |
1 | cupric sulfide (CuS)IBA
07/2018 |